The role of herbal medicine in the treatment of chronic tonsillitis

The article presents our own research data on systemic immunity status in patients with chronic tonsillitis (CT) and microbiological profile of the flora isolated from the tonsils in CT. The study showed that phagocytic index in neutrophils decreased by 81.9% and the phagocytosis in neutrophils reduced by 67.2% in patients with CT. We studied microbial flora of the tonsils and its persistent properties in CT. The steps for that were as follows: we evaluated the antilysocyme (ALA), anti-interferon (AIA), anticomplementary (ACA) activities of the isolated microorganisms as possible ways to stand against the oxygen-independent mechanism of phagocytosis. Most strains of Staphylococcus aureus had ALA, AIA and AСA, while most strains of Streptococcus pyogenes had ALA, less frequently AСA and did not show AIA. We found antibacterial polyresistance in 56.0% of pathogens among the selected strains in the examined patients with CT. A comparative analysis of species antibiotic resistance showed that the largest number of multiresistant strains were S.aureus - 62.0%. The set of revealed persistent properties of chronic tonsillitis pathogens serves as underlying rationale for the search for new methods of therapy using drugs of non-antibacterial origin, affecting the factors of bacteria resistance to inborn and acquired immunity. It is possible, and necessary that attention be paid to phytotherapy in the search for such new methods. Tonsilgon N is one of the complex phytotherapeutic products, which efficacy and safety has been proven in clinical trials, and the main pharmacological properties are confirmed in in vitro and in vivo preclinical studies. It contains marshmallow root, chamomile flowers, horsetail grass, walnut leaves, yarrow grass, oak bark, and dandelion grass. The clinical studies revealed that it has positive effect on the dynamics of both clinical and microbiological, immunological parameters in patients with chronic tonsillitis. All these things allow us to recommend that this complex herbal product be more often included into the comprehensive treatment of chronic tonsillitis. 

1. Gurov A.V., Aksenova A.V., Guseva O.A. The possibilities of modern macrolides in the prevention of associated diseases in chronic tonsillar pathology. В: Proceedings of the 1st St. Petersburg Forum of Otorhinolaryngologists of Russia. Sankt­Peterburg, 17­18 apr 2012. Sankt-Peterburg: Poliforum; 2012. Vol. 1, pp. 329–333. (In Russ.)

2. Pal’chun V.T., Gurov A.V., Aksenova A.V., Guseva O.A. The modern view of toxico-allergic manifestations of chronic tonsillar pathology, its etiological and pathological role in the evolvement and development of general diseases. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2012;77(2):5–12. (In Russ.) Available at: https://www.mediasphera.ru/issues/vestnik-otorinolaringologii/2012/2/downloads/ru/0300424668201221.

3. Belov V.A., Voropaeva Y.V. Age and gender characteristics of the prevalence of chronic tonsillitis in children. Meditsinskiy sovet = Medical Council. 2015;(1):18–21. (In Russ.) doi: 10.21518/2079-701X-2015-1-18-21.

4. Karpova E.P., Bozhatova M.L. Modern possibilities of antibacterial therapy in children with chronic tonsillitis. RMZH = RMJ. 2010;(1):8–10. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/Sovremennye_vozmoghnosti_antibakterialynoy__terapii_u_detey_s_hronicheskimi_tonzillitami/.

5. Pal’chun V.T., Polyakova T.S., Romanova O.N. Therapeutic and diagnostic approaches to the problem of chronic tonsillitis Bulletin of otorhinolaryngology. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2001;(1):4–7. (In Russ.)

6. Aznabaeva L.F., Aref’eva N.A. Immunological aspects of chronic tonsillitis. Bulletin of Otorhinolaryngology = Vestnik otorinolaringologii. 2013;78(4):4–9. (In Russ.) Available at: https://www.mediasphera.ru/issues/vestnik-otorinolaringologii/2013/4/030042-4668201341.

7. Kharayeva Z.F., Azamatova E.K. Factors of persistence of pathogens of chronic tonsillitis. In: Ilyinskikh N. (ed.). Issues and Perspectives in Contemporary Science. Tomsk; 2009. Vol. 2(1), pp. 234–235. (In Russ.)

8. Azamatova E.K., Charaeva Z.F., Malceva G.S. Сharacteristics of microbial properties of persistence in children with chronic tonsillitis. Rossiyskaya otorinolaringologiya = Russian Otorhinolaryngology. 2011;(3):3–6. (In Russ.) Available at: https://elibrary.ru/item.asp?id=16945061.

9. Selimzianova L.R., Vishneva E.A., Fedoseenko M.V., Promyslova E.A. Phytotherapy: Present State of the Issue. Pediatricheskaya farmakologiya = Pediatric Pharmacology. 2016;13(5):488–493. (In Russ.) doi: 10.15690/pf.v13i5.1645.

10. Miraj S., Alesaeidi S. A systematic review study of therapeutic effects of Matricaria recuitta chamomile (chamomile). Electron Physician. 2016;8(9):3024–3031. doi: 10.19082/3024.

11. Dayronas Zh.V., Kuleshova S.A., Pshukova I.V. Phytochemical study of walnut leaves as a source of antioxidants. Khimija rastitel’nogo syr’j = Chemistry of plant raw material. 2010;(4):95–98. (In Russ.) Available at: https://elibrary.ru/item.asp?id=15578097.

12. Kurkin V.A., Aznagulova A.V. Phytochemical study of aerial parts of taraxacum officinale wigg. Khimija rastitel’nogo syr’j = Chemistry of plant raw material. 2017;(1):99–105. (In Russ.) doi: 10.14258/jcprm.2017011027.

13. Mel’nikov O.F., Zabolotnyy D.I.. Immunomoduliruyushchiye svoystva fitopreparata Tonzilgon® N. Zdorov’ya Ukraїni = Health of Ukraine. 2006;(5):136–137. (In Russ.) Available at: https://www.bionorica.ru/rep/4_TonzilgonN/1_Pediatri/1_orvi-u-chbd/5_Melnikov_ImmsvvafitoprepTonz_2006.pdf.

14. Drynov G.I., Ivanyushina O.K., Dyakova F.N. Tonsilgon® N in Therapy of Chronic Tonsillitis in Children. Effektivnaya farmakoterapiya = Effective pharmacotherapy. 2014;(3):4–6. (In Russ.) Available at: https://umedp.ru/articles/preparat_tonzilgon_n_v_lechenii_khronicheskogo_tonzillita_u_detey.html.

15. Кryukov A.I., Kunelskaya N.L., Tsarapkin G.Y., Izotova G.N., Tovmasyan A.S., Luchsheva Y.V. The study of the efficacy and safety of Tonsilgon® N in the treatment of chronic pharyngitis. Meditsinskiy sovet = Medical Council. 2016;(17):42–44. (In Russ.) doi: 10.21518/2079-701X-2016-17-42-44.

16. Gurov A.V., Yushkina M.A. Opportunities of Tonsilgon® N use in complex treatment of chronic tonsillitis. Consilium Medicum. 2018;20(11):20–24. (In Russ.) doi: 10.26442/20751753.2018.11.000027.

17. Piskunov V.S., Nikitin N.A. Experience of the usage of Tonsilgon® N in the complex treatment of chronic tonsillitis with irrigations of palatine tonsils in adults. Consilium Medicum. 2018;20(3):48–52. (In Russ.) Available at: https://consilium.orscience.ru/upload/iblock/f81/f81df7c75ad00936821b25ce0ac0a598.pdf.

18. Feyzullayev E.F., Karpova E.P., Baykova V.N. Features of the antioxidant protection system and its correction in children with chronic tonsillitis. RMZH = RMJ. 2009;(4):303–307. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Osobennosti_sistemy_antioksidantnoy__zaschity_i_ee_korrekciya_u_detey__s_hronicheskim_tonzillitom/